会員ID：
パスワード：

キーワード	：

キーワード	：
メーカー略称	：選択	商品コード	：
製品区分	：	中止製品	：

キーワード	：
メーカー略称	：選択	商品コード	：
中止製品	：

抗原種ヘルプ	：	交差性ヘルプ	：	免疫動物ヘルプ	：
標識ヘルプ	：	適用ヘルプ	：	性状ヘルプ	：
吸収処理ヘルプ	：	クラスヘルプ	：	クローンヘルプ	：

製品区分	：	一致条件	：	中止製品	：

メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：
メーカー略称	：選択	商品コード	：

CAS番号	：

メーカー略称	：選択	中止製品	：

メーカー：	Horizon社Dharmacon製品 OriGene Technologies TransOMIC Technologies
	Horizon社Dharmacon製品(メーカー略称：DHA)のRNAiコレクション，cDNAコレクション，Yeastコレクションなど，遺伝子機能研究に有用な遺伝子リソースを検索することができます。クローンコレクション検索の使い方はこちら OriGene Technologies社(メーカー略称：ORI)のTrueClone / TrueORF / TrueORF Gold cDNAクローンなど，遺伝子機能研究に有用な遺伝子リソースを検索することができます。クローンコレクション検索の使い方はこちら TransOMIC Technologies社(メーカー略称：TOT)のRNAiコレクション，cDNAコレクション，Yeastコレクションなど，遺伝子機能研究に有用な遺伝子リソースを検索することができます。クローンコレクション検索の使い方はこちら
キーワード	：

WEBページ番号検索	：

HOME> 試薬> サイトカイン／増殖因子／ホルモン> ホルモンアッセイキット> Mercodia Webinars / Podcasts

糖尿病に関連した著名な科学者のウェビナーをご紹介します Mercodia Webinars / Podcasts

掲載日情報：2017/01/06 現在Webページ番号：64699

Mercodia社では、様々な科学分野の専門家と研究者の業績やインタビューをWebinarおよびPodcastで研究者の皆様に提供しています。

Mercodia社ウェビナーの講演者

タイトルをクリックすると、直接Webinarの視聴ページにジャンプします。講演者の写真をクリックすると、講演者とWebinarの内容の紹介がご覧いただけます。

Glucagon & Glicentin：Unique hormones from the Same Precursor Dr. Jens Juul Holst	Glucagon-A Therapeutic Target Dr. Alan D Cherrington	Glucagon Release with SGLT2 Inhibition Dr. Ralph DeFronzo
Advances in the Bionic Pancreas Dr. Steven Russell	Beta Cell Regeneration:Novel Sources Dr. Juan Dominguez-Bendala, Dr. Pedro Herrera	Leptin and Diabetes Dr. Jeffrey M. Friedman Dr. Roger Unger
Bariatric Surgery: Regulation of Gut and Islet Hormones Dr. David A. D’Alessio	Obesity, Adiponectin and Cancer Dr. Christos Mantzoros	Metabolic & Cardiovascular Complications of HIV Dr. Grace McComsey
Insulin and Glucagon Regulation in Health & Disease Dr. Patrik Rorsman	GLP-1 Secretion in Humans: Recent Advances Dr. Jens Juul Holst	NAFLD & NASH:Links to Obesity and Diabetes Dr. Kenneth Cusi (University of Florida)

目次に戻る

Mercodia社糖尿病研究関連ELISAキットシリーズ

Mercodia社は糖尿病を初めとする代謝関連の高品質なELISA キットを製造しているスウェーデンのメーカーです。Mercodia社ELISAキットは世界中の研究者に広くご使用いただいており、数多くの著名な論文誌に掲載されています。中でもMercodia Insulin ELISA Kitは米国糖尿病学会(ADA)協賛のインスリン測定法標準化のワークショップで唯一、総合測定誤差基準を満たすキットとして認定されています*。

* Miller WG., et al., Clin. Chem., 55, 1011～1018 (2009).

※ 因子または動物種をクリックすると詳細な製品情報、商品コードをクリックすると価格表をご覧いただけます。

測定因子	測定動物種	品名	商品コード	包装
Adiponectin	Human	Mercodia Adiponectin ELISA	10-1193-01	1×96 wells
C-peptide	Human	Mercodia C-peptide ELISA	10-1136-01	1×96 wells
	Human	Mercodia Ultrasensitive C-peptide ELISA	10-1141-01	1×96 wells
	Rat	Mercodia Rat C-peptide ELISA	10-1172-01	1×96 wells
	Porcine	Mercodia Porcine C-peptide ELISA	10-1256-01	1×96 wells
Glicentin	Human	Mercodia Glicentin	10-1273-01	1×96 wells
Glicentin	Rat	Mercodia Rat Glicentin ELISA	10-1275-01	1×96 wells
GLP-1	Human	Total GLP-1 NL-ELISA	10-1278-01	1×96 wells
Glucagon	Human	Mercodia Glucagon ELISA	10-1271-01	1×96 wells
IGFBP-4 fragment	Human	IGFBP-4 fragment ELISA	10-1276-01	1×96 wells
Insulin	-->Human	Mercodia Insulin ELISA	10-1113-01	1×96 wells
		Mercodia Insulin ELISA 10 pack	10-1113-10	10×96 wells
		Mercodia Ultrasensitive Insulin ELISA	10-1132-01	1×96 wells
	Mouse	Mercodia Mouse Insulin ELISA	10-1247-01	1×96 wells
		Mercodia Mouse Insulin ELISA 10 pack	10-1247-10	10 x 96 wells
		Mercodia Ultrasensitive Mouse Insulin ELISA	10-1249-01	1×96 wells
	Rat	Mercodia Rat Insulin ELISA	10-1250-01	1×96 wells
		Mercodia Rat Insulin ELISA 10 pack	10-1250-10	10×96 wells
		Mercodia Ultrasensitive Rat Insulin ELISA	10-1251-01	1×96 wells
		Mercodia High Range Rat Insulin ELISA	10-1145-01	1×96 wells
	Bovine	Mercodia Bovine Insulin ELISA	10-1201-01	1×96 wells
	Canine	Mercodia Canine Insulin ELISA	10-1203-01	1×96 wells
	Equine	Mercodia Equine Insulin ELISA	10-1205-01	1×96 wells
	Feline	Mercodia Feline Insulin ELISA	10-1233-01	1×96 wells
	Ovine	Mercodia Ovine Insulin ELISA	10-1202-01	1×96 wells
	Porcine	Mercodia Porcine Insulin ELISA	10-1200-01	1×96 wells
Iso-Insulin	Human	Mercodia Iso-Insulin ELISA	10-1128-01	1×96 wells
Leptin	Human	Mercodia Leptin ELISA	10-1199-01	1×96 wells
Lp(a)（Apolipoprotein a）	Human	Lp(a) ELISA	10-1106-01	1×96 wells
Myeloperoxidase	Human	Myeloperoxidase ELISA	10-1176-01	1×96 wells
Oxidized LDL	Human	Mercodia Oxidized LDL ELISA	10-1143-01	1×96 wells
Proinsulin	Human	Mercodia Proinsulin ELISA	10-1118-01	1×96 wells
Proinsulin	Rat/Mouse	Mercodia Rat/Mouse Proinsulin ELISA	10-1232-01	1×96 wells

目次に戻る

Mercodia社Webinors

Mercodia社のWebinorでは、様々な科学分野の専門家と研究者の皆様とを結びつけています。これらの教養を高めかつ有益な特別セッションは、現在や将来に意思決定を行う際の疑問点に対する答えをしばしば提供し、皆様のグループを支援することでしょう。

※ タイトルをクリックすると、講演者のWebinorがご覧いただけます。

1. Glucagon & Glicentin：Unique hormones from the Same Precursor
Dr. Jens Juul Holst	Glucagon and Glicentin are both made from proglucagon but these two hormones are unique in multiple ways. During this webinar, Dr. Holst discusses their physiological roles and technical challenges associated with the measurement of these biomarkers. Dr. Holst is a world-renowned expert in the diabetes and obesity fields, and his accomplishments include the isolation and characterization of GLP-1.
2. Glucagon-A Therapeutic Target
Dr.Alan D Cherrington	Glucagon is an important therapeutic target for multiple metabolic diseases. During this webinar, Dr. Cherrington provides insight into ways to target this glucose regulator. Dr. Cherrington is world-renowned for his contributions to the understanding of how the liver is regulated, by various hormones and neural mediators, to release or store glucose, depending on a variety of physiological conditions.
3. Glucagon Release with SGLT2 Inhibition
Dr. Ralph DeFronzo	Increased glucose excretion through SGLT2 inhibition is a new mode of treatment for type 2 diabetes mellitus (T2DM). During this webinar, Dr. DeFronzo presents intriguing results showing a paradoxical increase in glucagon and endogenous glucose production with SGLT2 inhibition. Dr. DeFronzo is a world-renowned clinician and researcher, who has helped define the biochemical and molecular disturbances responsible for insulin resistance in T2DM.
4. Advances in the Bionic Pancreas
Dr. Steven Russell	The management of type 1 diabetes mellitus (T1DM) has often been referred to as a “second job” for those with the disease. The need for close and careful glucose monitoring, multiple daily insulin injections as well as dangerous and sometimes fatal hypoglycemia has led researchers to develop a bihormonal (i.e., insulin & glucagon) bionic pancreas. During this webinar, Dr. Steven Russell discusses the advances that have been made in this project.
5. Beta Cell Regeneration:Novel Sources
Dr. Juan Dominguez-Bendala, Dr. Pedro Herrera	The loss of functional beta cells underlies the pathology of diabetes and has serious metabolic consequences in these patients. Thus, scientists are examining ways to replace these critical endocrine cells. During this webinar, two expert scientists discuss regeneration of pancreatic beta cells from stem cells, exocrine cells and alpha cells.
6. Leptin and Diabetes
Dr. Jeffrey M. Friedman Dr. Roger Unger	Leptin is an important hormone secreted by adipose tissue. It plays a critical role in a number of processes including energy regulation. During this webinar, two leading expert scientists discuss how leptin is connected to type 1 and type 2 diabetes, including a link to glucagon.
7. Bariatric Surgery: Regulation of Gut and Islet Hormones
Dr. David A. D’Alessio	Bariatric surgery is proven to be highly effective for the treatment of obesity. These procedures not only affect hormones in the gut but have an impact on islet hormones that regulate glucose metabolism. Dr. D’Alessio is a highly regarded physician and scientist, who is known for his expertise in the field of endocrinology. During this webinar, he discusses the impact of bariatric surgery on incretins (e.g., GLP-1) and islet hormones (e.g., insulin and glucagon).
8. Obesity, Adiponectin and Cancer
Dr. Christos Mantzoros	Excess body weight is associated with an increased risk for a number of cancers. Adiponectin is an important adipokine that has been shown to have antiproliferative and proapoptotic properties. In addition, levels of adiponectin have been inversely associated with cancer risk. During this webinar, a leading expert will discuss scientific evidence connecting adiponectin and cancer risk.
9. Metabolic & Cardiovascular Complications of HIV
Dr. Grace McComsey	Millions of people, worldwide, are living with HIV. Common co-morbidities of this disease include lipodystrophy and premature atherosclerosis. The metabolic and cardiovascular complications associated with HIV have become of increasing importance for understanding pathogenesis of HIV and how these complications may be contributing to the persistent state of immune activation in HIV despite successful treatment. During this webinar, a world-renowned expert will present on the current understanding of these complications in HIV-infected adults.
10. Insulin and Glucagon Regulation in Health & Disease
Dr. Patrik Rorsman	Insulin and glucagon work in concert to modulate blood glucose levels. The release of these hormones, from pancreatic islets, is a highly regulated process that involves complex pathways.During this webinar, a leading expert will present data on precise mechanisms regulating the secretion of these two hormones under normal conditions. He will also discuss how these pathways go awry during diabetes and how they may be targeted by therapeutic strategies.
11. GLP-1 Secretion in Humans: Recent Advances
Dr. Jens Juul Holst	There is no doubt that gut hormones play an important role in human physiology. Perhaps the most famous of these hormones is the incretin GLP-1. During this webinar, one of the foremost experts on GLP-1 will focus on how the secretion of this gut hormone is regulated, including well-established and novel pathways.
12. NAFLD & NASH:Links to Obesity and Diabetes
Dr. Kenneth Cusi (University of Florida)	NAFLD is characterized by increased fat accumulation in the liver, and in the case of NASH, can lead to liver damage. Uncovering metabolic causes & consequences of NAFLD is key to understanding the etiology and treatment of this disease. During this webinar, one of the foremost experts will discuss the pathophysiology of NAFLD, with particular focus on links to obesity and diabetes.

※ QuickTimeでは、本ファイルを適切にご覧いただけない可能性があります。このWebinarを視聴する際に不都合がある場合には、無償のVLC playerをダウンロードして下さい。

目次に戻る

Mercodia社Podcastsのリスト

創薬・代謝性疾患（例えば、糖尿病や心臓病）に対する新規のアプローチに新しいFDAの規制に至るまでのトピックについて、科学者や臨床医のインタビューを通して最先端の情報をお届けします。

※ タイトルをクリックすると、科学者や臨床医のインタビューを聴講いただけます。

No.	Title	Abstract
1	Targeting Diabetes with an Old TB Vaccine	Dr. Denise Faustman discusses her serendipitous and revolutionary finding about the progression of diabetes while conducting novel trials on the use of an old TB vaccine.
2	Lowering OxLDL with a Novel Fiber	Dr. Joseph Evans shares results from a recent clinical trial showing a reduction in a key mediator of atherosclerosis after supplementation with a novel dietary fiber.
3	C-peptide as a Therapy for Patients with T1DM	Dr. John Wahren provides intriguing insight into the use of a protein that was once thought to have no biological activity, as a way to treat diabetic complications.
4	Bariatric Surgery vs Intensive Medical Mgmt for the Treatment of T2DM	Dr. Allison Goldfine discusses the first round of results from the exciting SLIMM-T2D study and their plan for the lapband portion of the clinical trial.
5	Taking a Closer Look at Glucagon	Dr. Jens Holst discusses the hormone glucagon, including how it is affected by GLP-1 and various physiological conditions and diseases, as well as important measurement considerations.
6	Two Novel Devices for Diabetes	Find out about a unique handheld device that checks for peripheral neuropathy and the world’s smallest, portable glucose meter.
7	Life with a Bionic Pancreas: A Clinical Trial Subject’s Perspective	Kelly Close, a patient with type 1 diabetes, shares her personal experience as a subject in a revolutionary bionic pancreas trial.
8	Treating T2DM through the Small Intestine	Dr. Harith Rajagopalan describes his company’s innovative procedure, Revita Duodenal Mucosal Resurfacing (DMR), and its beneficial effects on T2DM and weight.

目次に戻る

お問い合わせ先

（テクニカルサポート試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。